Maximillian-Alexander Röhnert

7PUBLICATIONS
46CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 08, 2026
Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications.

Jonas Schadt, Malte von Bonin, Uta Oelschlägel

|Mar 20, 2026
Steady-state mobilization with on-demand plerixafor after CD38 antibody-based induction in multiple myeloma patients.

Maximilian Alexander Röhnert, Anna Seifert, Karolin Trautmann-Grill

|Feb 16, 2026
Measurable residual disease by multicolor flow cytometry in acute myeloid leukemia: A comparison of peripheral blood and bone marrow.

Jonas Schadt, Malte von Bonin, Uta Oelschlägel

|Oct 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner

|Oct 09, 2025
Independent confirmation of the immunophenotypic ELN Scoring System in patients with MDS and CMML.

Uta Oelschlaegel, Jonas Schadt, Katharina Epp

|Jan 16, 2024
MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms.

Uta Oelschlaegel, Susann Winter, Katja Sockel

Pageof 2

Frequent Collaborators

4 joint publications

Christoph Röllig

4 joint publications

Martin Bornhäuser

4 joint publications

Uta Oelschlägel

3 joint publications

Jonas Schadt